Companies Dominating the Bile Acid Sequestrants Market
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AstraZeneca Plc
- Ecogene
- Novartis International AG
- Sanofi S.A.
- Amgen Inc.
- Merck & Co., Inc.
- AbbVie Inc.
- GlaxoSmithKline plc.
- Octapharma AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of bile acid sequestrants is evaluated at USD 21.8 billion.
The bile acid sequestrants market size was over USD 20.46 billion in 2024 and is poised to exceed USD 53.67 billion by 2037, witnessing over 7.7% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of hyperlipidemia worldwide will fuel the market growth.
North America industry is predicted to dominate majority revenue share of 32% by 2037, owing to increasing cases of hyperlipidemia in the region.
The major players in the market are Pfizer Inc., AstraZeneca Plc, Ecogene, Novartis International AG, Sanofi S.A., Amgen Inc., Merck & Co., Inc., AbbVie Inc., GlaxoSmithKline plc., Octapharma AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Mochida Pharmaceutical Co., Ltd., Astellas Pharma Inc.
